| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $163.4M | +21.9% |
| Cost of Revenue | $3.7M | -57.4% |
| R&D Expense | $234.1M | +24.7% |
| SG&A Expense | $136.5M | +13.6% |
| Operating Income | -$211.0M | -15.5% |
| Pre-tax Income | -$194.5M | -9.1% |
| Income Tax | $431K | — |
| Net Income | -$194.9M | -8.9% |
| EPS (Basic) | -$2.29 | +3.4% |
| EPS (Diluted) | -$2.29 | +3.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.5M | +29.0% |
| Short-term Investments | $222.7M | -14.3% |
| Accounts Receivable | $32.0M | +42.5% |
| Inventory | $21.2M | +3.2% |
| Current Assets | $381.1M | -3.0% |
| Total Assets | $473.6M | +4.3% |
| Current Liabilities | $100.3M | +16.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$146.7M | +4.0% |
| Capital Expenditures | $778K | -7.5% |
| Investing Cash Flow | $12.5M | +136.6% |
| Financing Cash Flow | $152.0M | -7.9% |
| Free Cash Flow | -$147.5M | +4.1% |
| Total Liabilities |
| $122.7M |
| +9.2% |
| Stockholders' Equity | $350.9M | +2.7% |